Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSANTOS, Debora de OliveiraLOYOLA, Adriano MotaCARDOSO, Sergio VitorinoCHAMMAS, RogerLIU, Fu-TongFARIA, Paulo Rogerio de2015-04-222015-04-222014EXPERIMENTAL AND MOLECULAR PATHOLOGY, v.97, n.3, p.332-337, 20140014-4800https://observatorio.fm.usp.br/handle/OPI/8953Oral squamous cell carcinoma (OSCC) is one of the most aggressive cancers of the oral cavity and an important cause of death worldwide. Currently, there are limited clinical tools aiding clinicians to establish its early diagnosis, and genetic and epigenetic events leading to the pathogenesis of OSCC remain unsolved. The use of carcinogen-induced knocked out mouse models would help to improve its early detection and also determine the role of proteins such as galectin-3 (Gal3) in this process. Here we used a mouse model of oral carcinogenesis employing two mouse genotypes: wild-type (Gal3 +/+) and galectin-3-deficient mice (Gal3 -/-) challenged by the carcinogen 4NQO for 16 weeks. After induction, the expression of Wnt1, Wnt3A, Shh and Gli3 proteins in tongue samples was evaluated using an immunohistochemistry approach. All samples of dysplasia and carcinoma were negative for Wnt1. Wnt3A expression was detected in both Gal3 +/+ and Gal3 -/- mice, at similar levels. Wnt3A expression did not predict tongue tumorigenesis in either genotype. Dysplastic- and carcinoma-expressing Shh was statistically significantly higher in Gal3 +/+ mice than Gal3 -/- mice (p < 0.0001), and was associated with tongue tumorigenesis only in the former. Gli3 expression decreased and increased from dysplasia to carcinoma in Gal3 +/+ and Gal3 -/- mice, respectively, although the difference was not significant. The results suggest that activated Wnt signaling is present in both mice, and that the Hh signaling pathway might play a role in tongue carcinoma development in Gal3 +/+ mice.engrestrictedAccessOral carcinogenesisGalectin-3TongueMiceSonic hedgehogWnt signalingsquamous-cell carcinomasonic hedgehogbeta-catenintargeted disruptionoral carcinogenesisnegative regulatorgalectin-3cancerexpressionprogressionarticleCopyright ACADEMIC PRESS INC ELSEVIER SCIENCE10.1016/j.yexmp.2014.09.018Pathology1096-0945